Klaus H. Metzeler

University Hospital Leipzig — Germany

Medicine · Health Sciences

56h-index12.9kcitations431works3.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(283), Myeloproliferative Neoplasms: Diagnosis and Treatment(99), Cancer Genomics and Diagnostics(76), Chronic Myeloid Leukemia Treatments(56), CAR-T cell therapy research(52)

Publications431 total

Nationwide analysis of acute promyelocytic leukemia: incidence and patient outcomes in Germany
Haematologica·2026Open Access
MyCARdiac score: integrating cardiac imaging and biomarkers to predict outcomes in RRMM patients receiving cilta-cel
Leukemia·2026Open Access
The induction regimen does not affect stem cell collection in adult patients with Ewing sarcoma
Transfusion Medicine and Hemotherapy·2026Open Access
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia
Leukemia·2026Open Access
Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis
Transfusion Medicine and Hemotherapy·2026Open Access
Prähabilitation vor einer allogenen Blutstammzelltransplantation bei hämatologischen Neoplasien
Die Onkologie·2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia – a HARMONY study
Leukemia·2026Open Access
Who Am I? Eyebrow Follicles Minimize Donor-Derived DNA for Germline Testing After Hematopoietic Stem Cell Transplantation
International Journal of Molecular Sciences·2026Open Access
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation
Bone Marrow Transplantation·2025Open Access
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma
Cancer Cell·2025Open Access
Venetoclax combined with five days of azacitidine for the treatment of previously untreated Acute Myeloid Leukemia (AML): Initial results of the prospective venaza-5S trial
Blood·2025Open Access
Venetoclax in combination with hypomethylating agents in adult patients with newly diagnosed AML with CBFB::MYH11 or RUNX1::RUNX1T1 fusions: Real-world outcomes based on international registry data
Blood·2025Open Access
MPN with multiple driver clones show distinct patterns of therapy response and progression - “MPN double driver”
Blood·2025Open Access
Validation of measurable residual disease as a surrogate endpoint in acute myeloid leukemia: A HARMONY Alliance study of European randomized trials
Blood·2025· 1 citedOpen Access
The presence of SH2B3 mutations identifies a distinct subtype of myelodysplastic neoplasms
Blood·2025Open Access
Impact of renal impairment and lymphodepletion regimen on outcomes after CAR T-cell therapy in relapsed/refractory multiple myeloma
Blood·2025Open Access
Single versus double “7+3” induction with 60 versus 90 mg/m2 daunorubicin in newly diagnosed AML: Does it matter for NPM1 MRD?
Blood·2025
Preliminary pharmacokinetic and MRD results from AML patients treated with 7- and 14-day dosing schedule of emavusertib added to combination therapy with azacitidine and venetoclax
Blood·2025Open Access
Spatiotemporal and genetic tracking of long-term persisting CAR-T cells following ciltacabtagene autoleucel treatment for multiple myeloma reveals molecular insights into late-onset toxicities
Blood·2025
Independent, international validation of the unsupervised harmony classification of Acute Myeloid Leukemia
Blood·2025
page 1 of 22Next →

Frequent Co-authors

Karsten Spiekermann(29), Wolfgang Hiddemann(23), Stefan K. Bohlander(22), Tobias Herold(17), Guido Marcucci(17), Clara D. Bloomfield(17), Susan P. Whitman(15), Jan Braess(15), Wolfgang E. Berdel(14), Kati Maharry(14), Krzysztof Mrózek(14), Heiko Becker(14), Jonathan E. Kolitz(14), Bianka Ksienzyk(14), Sebastian Schwind(13), Bayard L. Powell(13), Andrew J. Carroll(12), Maria R. Baer(12), Michael A. Caligiuri(12), Richard A. Larson(12)